Why Humana stock moves
Humana barely moved, less than the market.
Written after the close on ·
Why today
16,307 news analyzed todayHumana barely moved, less than the market.
It was an ordinary day for Humana, with trading well below its usual level.
OMX Stockholm 30 rose clearly over the same day, while Humana stayed roughly flat.
Over the last five trading days Humana was roughly unchanged, while the market fell slightly.
No company news from the last session explains the move; the Q3 report came out before it.
Today's move of +0.00% was 0.0 times a normal day's 0.8%. OMX Stockholm 30 moved +1.57% on the same day.
Humana +0.00%OMX Stockholm 30 +1.57%Much weaker than the market
What analysts expect, and how often they have been right
Analysts’ estimates for Humana.
Ratings
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor. October 6: Sell about 539 thousand SEK. April 24: Buy about 250 thousand SEK. February 26: Buy about 47 thousand SEK. February 25: Buy about 65 thousand SEK. February 9: Buy about 27 thousand SEK.
Has the share price followed the business?
Price and earnings moved in the same direction: 2 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed +41% and earnings per share +65%.
Revenue, profit and market cap
RevenueProfitMarket capbn SEK
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn SEK
Price and earnings moved in the same direction: 2 out of 3 years.Market cap (Now): 3.4 bn SEKRevenue 2025: 10.0 bn SEK
What the key figures say about Humana
The figures connect what Humana earns with what investors pay.
The line shows the share price in the same year, on its own scale.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: 2.87 SEK–4.73 SEK. Peers: Pihlajalinna 0.79 EUR, Terveystalo 0.45 EUR, COMPASS Pathways -$2.34.
What the company sold during the year.
2022–2025: 9.2 bn SEK–10.3 bn SEK. Peers: Pihlajalinna 542 m EUR, Terveystalo 1.2 bn EUR.
The percentage of revenue left after the costs of running the business.
2022–2025: 3.9%–4.9%. Peers: Pihlajalinna 6.1%, Terveystalo 8.0%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: 4.6%–7.7%. Peers: Pihlajalinna 10.8%, Terveystalo 10.4%, COMPASS Pathways −296.5%.
The price investors pay for each unit of annual earnings per share. Not shown for a loss.
2022–2025: 7.6–12.4. Peers: Pihlajalinna 10.6, Terveystalo 13.8.
What investors pay for each unit the company sells.
2022–2025: 0.14–0.24. Peers: Pihlajalinna 0.35, Terveystalo 0.66.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: 3.64–5.25. Peers: Pihlajalinna 6.77, Terveystalo 4.22.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 0.47–0.78. Peers: Pihlajalinna 1.10, Terveystalo 1.47, COMPASS Pathways 8.58.
Market cap plus net debt, divided by operating earnings. This includes debt.
2022–2025: 12.4–14.9.
Cash left after investments, divided by the number of shares.
2022–2025: 12.98 SEK–16.77 SEK. Peers: Pihlajalinna 1.87 EUR, Terveystalo 0.73 EUR, COMPASS Pathways -$1.25.
The percentage of assets financed by shareholders’ equity.
2022–2025: 27.9%–33.2%.
What to watch next, and why
The earnings report shows how Humana's revenue and profit have changed.
- Earnings report
The earnings report shows how Humana's revenue and profit have changed.
Add to calendar
More about Humana
Insider trades
People on the board and in management must report their trades in the share to Finansinspektionen, Sweden's financial supervisor.
- Titti Lilja, senior executiveSellabout 539 thousand SEK
- Nathalie Boulas Nilsson, CEOBuyabout 250 thousand SEK
- Grethe Aasved, board memberBuyabout 47 thousand SEK
- Nathalie Boulas Nilsson, CEOBuyabout 65 thousand SEK
- Christoffer Herou, CFOBuyabout 27 thousand SEK
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Humana usually moved about 6.0%. On a normal day it moves 0.8%.
+0.28% −0.95% −5.53% −12.76%
10,000 SEK in Humana bought on October 26, 2016 is worth 9,960 SEK today, with dividends reinvested.
What would 10,000 SEK in Humana be worth today? →
What would 10,000 SEK in Humana be worth today?
9,960 SEK
with dividends reinvested, bought on October 26, 2016.
At worst it was worth 1,660 SEK (March 28, 2023).
The five biggest days of the journey
· −49.9% · the whole market fell 0.1% the same day
· +47.7% · the whole market fell 0.7% the same day
· +29.2% · the whole market rose 0.4% the same day
· +16.7% · the whole market fell 0.5% the same day · report day
· −14.7% · the whole market fell 0.5% the same day
Earlier days
+0.85% market +2.55% Humana rose slightly this week, while the broader Stockholm market rose clearly, so it moved less than the market. Read →
Humana rose slightly this week, while the broader Stockholm market rose clearly, so it moved less than the market.
The Q3 report on 22 October, which showed its highest quarterly operating profit and a better margin, was the most relevant company news, though it came before this week's trading days.
Trading was quiet and the move was ordinary in size.
Its next earnings report is due on 5 February 2027.
−0.14% market +0.41% Humana barely moved, far less than the market. Read →
Humana barely moved, far less than the market.
Humana was roughly unchanged while OMX Stockholm 30 rose slightly.
The company reported its best quarterly operating profit ever, with a better profit margin.
Over five trading days Humana was roughly flat, while the market fell sharply.
+0.00% market −3.67% Humana was roughly flat over the last five trading days. Read →
Humana was roughly flat over the last five trading days.
The market fell sharply over the same days, so Humana held up much better than the broader market.
The company published its third-quarter report yesterday, showing its highest quarterly operating profit ever and a stronger margin, though organic growth was only slightly positive.
Trading was quiet and the move was ordinary in size.
−0.14% market +0.17% Humana was roughly unchanged, in line with a flat market. Read →
Humana was roughly unchanged, in line with a flat market.
No company news came out during that session.
Over the last five trading days, Humana fell slightly, moving in line with OMX Stockholm 30.
The main driver is the takeover: Ambea's offer has closed and it controls about 98 percent of the shares.
Nasdaq Stockholm will delist the shares, with the last trading day on 27 October 2026.
+0.14% market −0.89% Humana stock moved without company news. Read →
Humana stock moved without company news.
Humana was roughly unchanged while OMX Stockholm 30 fell clearly, so it held up better than the market.
Over the last five trading days Humana fell clearly, while the market fell only slightly.
Earlier news explains most of the weakness: Ambea's takeover offer closed, Ambea now controls 98 percent of the shares, and Nasdaq Stockholm will delist Humana.
The last trading day is 27 October 2026.
+0.00% market +1.25% Humana roughly unchanged, while the market rose clearly. Read →
Humana roughly unchanged, while the market rose clearly.
Earlier this week, Nasdaq Stockholm decided to delist Humana, with the last day of trading set for late October, which likely weighs on the share as investors look to exit.
Over the last five trading days, Humana fell sharply while OMX Stockholm 30 rose slightly.
Next, the company reports results on 22 October, the last scheduled report before the delisting.
−7.50% market +1.19% Humana (listed on Nasdaq Stockholm) fell sharply over the last five trading days, while the broader OMX Stockholm 30 index rose slightly, so the company moved against the market. Read →
Humana (listed on Nasdaq Stockholm) fell sharply over the last five trading days, while the broader OMX Stockholm 30 index rose slightly, so the company moved against the market.
The most likely driver is company news earlier in the week: Nasdaq Stockholm decided to delist Humana, meaning the share will be removed from the exchange, with the last day of trading set for late October.
Investors often sell down a share once its exchange listing is ending, because it becomes harder to trade and some funds must exit holdings.
The stock was roughly unchanged in the latest session, while the market rose clearly.
−1.13% market −0.62% Humana fell slightly, more than the market. Read →
Humana fell slightly, more than the market.
Over the last five trading days it fell clearly while OMX Stockholm 30 rose clearly.
The most likely reason is news from earlier this week that Nasdaq Stockholm will delist Humana, with the last day of trading set for 27 October 2026.
Delisting means the shares will no longer be traded on the exchange, which typically weighs on the price as investors reduce exposure.
The next earnings report is due 22 October 2026.
−2.87% market −0.02% Humana fell sharply, against a roughly flat market, likely on the news that Nasdaq Stockholm will delist the company. Read →
Humana fell sharply, against a roughly flat market, likely on the news that Nasdaq Stockholm will delist the company.
Humana, listed on Nasdaq Stockholm, fell slightly over the last five trading days while the OMX Stockholm 30 rose slightly, so the stock lagged the broader market.
The sharp drop in the last session most likely reflects the announcement that Nasdaq Stockholm has decided to delist Humana AB, with the last day of trading set for 27 October 2026.
Delisting means the shares will be removed from the exchange, which typically reduces liquidity and makes the stock harder to buy and sell, and investors often sell ahead of that.
The company's third-quarter report is due on 22 October 2026, which is the next event to watch.
−2.37% market +0.36% Humana fell on takeover mechanics. Read →
Humana fell on takeover mechanics.
Humana drifted slightly higher over the last five trading days, outpacing a flat Stockholm market, as Ambea's completed takeover — declared unconditional at the start of the month, with Ambea now holding over 90% of the shares — left the stock pinned near the offer and the board applying to delist from Nasdaq Stockholm, with an extraordinary general meeting called for shareholder votes on the new board.
The last session's clear drop likely reflects the approach of delisting and compulsory buyout of the remaining shares, which caps the price near the offer and makes the stock trade on deal mechanics rather than company news; the appointment of an acting head of Humana Assistans is routine and not a driver.
Watch next week's earnings report and any confirmed last day of trading.
Learn more · Why do stocks go up and down?